Wisconsin Roundup: TAI Diagnostics, WhyHigh, DevCodeCamp & More

(Page 2 of 2)

will provide more than $1 million to fund research in health disparities, cardiovascular health, and other areas affecting patients and communities in the Milwaukee area. CTSI is a consortium of eight regional organizations including the Medical College of Wisconsin, the University of Wisconsin-Milwaukee, and Marquette University. CTSI received the grant as part of its Pilot Transactional and Clinical Studies Program, which launched in 2009 and receives funding from the NIH.

—In medical radioisotope news, Madison-based NorthStar Medical Radioisotopes received a $11.8 million grant from the National Nuclear Security Administration, part of the U.S. Department of Energy. NorthStar said it will use the funding to continue its march toward commercial production of molybdenum-99, the material that decays into technetium-99m, the most widely used in medical diagnostic imaging.

One of NorthStar’s rivals in the quest to make molybdenum-99 in the U.S. is Shine Medical Technologies, which is also headquartered in Madison. The neutron-generating particle accelerator technology Shine plans to use to produce the isotope was developed by Phoenix Nuclear Labs—also of Madison—whose accelerator has additional applications, in fields like defense and energy.

—EnSync (NYSE: ESNC)—formerly ZBB Energy—named former Integrys Energy Group CFO Jim Schott to the same position, Seeking Alpha reported. Shares in EnSync, a Milwaukee-area company that makes energy management systems, were down nearly 11 percent following the announcement. However, shares rallied and ended the week at $0.53, just above where the stock was trading before EnSync announced Schott’s hiring.

Single PageCurrently on Page: 1 2 previous page